The anatomic pathology market is a significant segment of the global healthcare industry. Anatomic pathology involves the examination of tissue samples and cells to diagnose diseases, determine their extent, and guide treatment decisions. This branch of pathology plays a crucial role in cancer diagnosis and monitoring, infectious disease identification, and other medical conditions.
The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
Key factors driving the growth of the anatomic pathology market included:
Increasing Incidence of Cancer: With the rising global incidence of cancer and the need for accurate and timely diagnoses, demand for anatomic pathology services has been on the rise.
Technological Advancements: Advancements in digital pathology, automation, and molecular testing techniques have improved the efficiency and accuracy of anatomic pathology services, attracting more healthcare providers to adopt these technologies.
Aging Population: The aging population is more prone to various diseases, including cancer, which boosts the demand for anatomic pathology services.
Growing Awareness: Increased awareness among patients and healthcare professionals about the importance of early and accurate diagnosis has driven the demand for anatomic pathology services.
Personalized Medicine: The trend towards personalized medicine, which tailors treatment based on an individual’s genetic makeup, has created a need for advanced pathology services, including molecular testing and genetic analysis.
Rising Healthcare Expenditure: As global healthcare expenditure continues to increase, there is a proportional rise in the demand for diagnostic services like anatomic pathology.
The anatomic pathology market has emerged as a critical component of the global healthcare industry, playing a pivotal role in diagnosing and managing various diseases, particularly cancer. With the increasing incidence of cancer worldwide and the growing demand for accurate and timely diagnoses, the demand for anatomic pathology services has been on the rise.
Key Market Players
The global anatomic pathology market for instruments and consumables is consolidated. The top five companies in this market are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Beckton, Dickson and Company (US), and Abcam plc. (UK).
F. Hoffmann-La Roche AG (Switzerland) was the leading player in the anatomic pathology market. The company has a wide range of products in the consumables segment. Strong business operations across all key regions, coupled with a strong brand image, make the firm a leading player in this market. F. Hoffman-La Roche has adopted organic business strategies such as product launches in order to maintain its leading position in the anatomic pathology market.
Danaher Corporation (US) was the second-leading player in the anatomic pathology market. The company has a broad product portfolio in the instruments segment. Moreover, Danaher also has a strong geographic presence with its direct distribution channels across the globe. The impressive product portfolio of the firm is complemented by its client support services. Over the years, Danaher has maintained its leading position in the market through continuous innovation and the launch of advanced products.
North America dominates the anatomic pathology market
The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.
Recent Developments:
- Hologic received premarket approval (PMA) from the FDA for its ThinPrep GenesisTM processor for cytology processing and specimen transfer for downstream applications.
- PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business to strengthen its position in the diagnostics segment.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=137323145
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html